Cargando…
Diphtheria toxin‐based anti‐human CD19 immunotoxin for targeting human CD19(+) tumors
CD19 is expressed on normal and neoplastic B cells and is a promising target for immunotherapy. However, there is still an unmet need to further develop novel therapeutic drugs for the treatment of the refractory/relapsing human CD19(+) tumors. We have developed a diphtheria toxin‐based anti‐human C...
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5527461/ https://www.ncbi.nlm.nih.gov/pubmed/28306193 http://dx.doi.org/10.1002/1878-0261.12056 |